SMi Group announces the return of its 11th annual Pharmaceutical Logistics conference to London on the 18th- 19th May 2017. Outsourcing logistics tasks to third parties has been observed as an emerging trend in the global market and it is only expected to gain momentum in the coming years
Pharma IQ brings you Clinical Trial Supply Europe Conference Profit. Successfully cutting costs and overages whilst increasing the flexibility and reactivity of your clinical supply network to support global clinical trials.
NeoGenomics Company Overview 2014-09-12 includes the following sections:
-Forward-looking Statements
-Investment Highlights
-Experienced Management Team
-Company Overview
-Proven Track Record Of Consistent Growth
-U.S. Cancer Testing Market Size $10-12 Billion
-NeoGenomics' Cancer Testing Services
-Customer Targets
-Accelerating Pace of Innovation
-90+ New Assays Launched Since January 2012
-A Growing Commercial & Facility Footprint
-Acquisition of Path Logic
-Strategic Alliance
-2014 and 2015 Strategic Priorities
-Accelerating Cash Flow & Earnings
-Adjusted EBITDA Metrics
- And much more...
Pharma IQ brings you Clinical Trial Supply Europe Conference Profit. Successfully cutting costs and overages whilst increasing the flexibility and reactivity of your clinical supply network to support global clinical trials.
NeoGenomics Company Overview 2014-09-12 includes the following sections:
-Forward-looking Statements
-Investment Highlights
-Experienced Management Team
-Company Overview
-Proven Track Record Of Consistent Growth
-U.S. Cancer Testing Market Size $10-12 Billion
-NeoGenomics' Cancer Testing Services
-Customer Targets
-Accelerating Pace of Innovation
-90+ New Assays Launched Since January 2012
-A Growing Commercial & Facility Footprint
-Acquisition of Path Logic
-Strategic Alliance
-2014 and 2015 Strategic Priorities
-Accelerating Cash Flow & Earnings
-Adjusted EBITDA Metrics
- And much more...
Healthcare logistics for service improvement and a new understanding of patient flow. Presented by Delia Dent, CSC, at HINZ 2014, 11 November 2014, 11.37am, Marlborough Room
Waste in hospitals - everywhere - is massive. Up to 50% of consumables and devices purchased are never used on a patient. Support activities are highly manual, repetitive and done by professional clinical staff...
This presentation sets out the strategic environment and discusses the development and successful implementation of a leading-edge process and supply chain solution for hospitals.
Operations: Top Reasons for Long Lead Times and What to Do About ThemApril Bright
Long lead times remain one of the most vocalized challenges that orthopedic manufacturers face today. Customers, profits, plans and personnel are all negatively impacted by them. James Kwan has worked on the OEM and the supplier sides of orthopedics, and shared his ideas and successful experiences to help you optimally respond to lead times, reduce them and ultimately create and sustain an agile supply chain.
Prof Clive Badman OBE
Presentation at EIPG - Royal Pharmaceutical Society Scientific Symposium "Advances in Technology Impacting the Pharmaceutical Industry" at the University of Strathclyde, Glasgow 2015.
Ongoing, monthly FSMA webcast series featuring The Acheson Group.
In the April 2018 session, Cameron Prince, Senior Food Safety Director with The Acheson Group, joined us for an update on current FSMA activities and to discuss the Safe Food For Canadians Act. Cameron provided an overview of the key elements of the act and proposed regulations and the impact on current food safety environment.
To learn more about this ongoing series, visit www.FSMAFridays.com.
7th Pharmacovigilance 2014 “Ensuring safer drugs to market by analyzing latest developments in pharmacovigilance, drug safety and risk management" 21st November 2014, Kohinoor Continental Hotel, Mumbai, India Greetings from Virtue Insight, I am happy to invite you and your colleagues to be a sponsor / delegate for our upcoming conference. The “Ensuring safer drugs to market by analyzing latest developments in pharmacovigilance, drug safety and risk management” at 7th Pharmacovigilance 2014 on 21st November 2014, Kohinoor Continental Hotel, Mumbai, India.Contact:-Tel: +91 9677590192 Email: dinesh@virtueinsight.co.in
The biotech industry is characterised by constant change and fast-paced growth. Keeping up with the rapid evolution is close to impossible. Nevertheless, that’s exactly what Niels Guldager, Senior Technology Partner within biopharmaceuticals, does best. In this slide series, he presents the top ten biotech trends as he sees them.
Counterfeit Herbal Medicine adulterated with chemical drugs in Indonesia: NAD...Premier Publishers
Herbal medicine is widely used in Indonesia. Thus, counterfeit herbal medicines are a great concern given the negative impact to individual and population health. This paper used data drawn from the National Agency of Drug and Food Control (NADFC/BPOM)of Indonesia to describe the counterfeit trend against registered herbal drugs from 2011 to 2014, and further analyses were performed to discover the types of the fraud, the impact to the health and conventional drugs that could be used as substitutes for herbal drugs. The research found that the amount of falsified medicines is increasing along with the increasing number of registered herbal drugs. From the data obtained, similar falsified herbal drugs were identified for both life style drugs (51%) and health-related condition drugs (49%). In addition, almost all falsified herbal drugs are adulterations plus tampering (81%). The most significant substitute chemical drug is paracetamol.
Counterfeit Products are epidemic in all product categories, but - unlike luxury goods – fakes and counterfeit pharmaceutical products endanger lives, either through their lack of active ingredients or the inclusion of harmful substances.
(The WHO estimates that over 30% of pharmaceuticals in developing countries are fake).
In this document, we would like to request your support for a field study of our latest mobile visual forensics application that is intended to provide quick, reliable and cost effective identification of counterfeit pharmaceutical goods.
http://www.e-mundo.de
From documents to datasets and back: challenges and solutions Jan Voskuil
The upcoming effectuation of the IDMP directive (EU) forces pharma companies to submit datasets instead of documents. Based on state of the art entity extraction software, a solution is developed that generates those parts of the dataset that can be obtained from the text. The presentation describes some of the major challenges that had to be overcome and details the solutions that were found. It presents some results and describes the major business requirements that need to be met. Recognizing named entities, such as headache and nausea, in the text is not enough. The extraction software needs to be embedded in a layer of software that analyses the text and recognizes which entities are the value of which properties.
The Falsified Medicines Directive - Regulation Driving DigitisationAegate
"The Falsified Medicines Directive - Regulation Driving Digitisation" by Graham Smith of Aegate.
Presented at The European Generic Medicines Association’s Annual Conference, Madrid
June 25-27th 2014
Healthcare logistics for service improvement and a new understanding of patient flow. Presented by Delia Dent, CSC, at HINZ 2014, 11 November 2014, 11.37am, Marlborough Room
Waste in hospitals - everywhere - is massive. Up to 50% of consumables and devices purchased are never used on a patient. Support activities are highly manual, repetitive and done by professional clinical staff...
This presentation sets out the strategic environment and discusses the development and successful implementation of a leading-edge process and supply chain solution for hospitals.
Operations: Top Reasons for Long Lead Times and What to Do About ThemApril Bright
Long lead times remain one of the most vocalized challenges that orthopedic manufacturers face today. Customers, profits, plans and personnel are all negatively impacted by them. James Kwan has worked on the OEM and the supplier sides of orthopedics, and shared his ideas and successful experiences to help you optimally respond to lead times, reduce them and ultimately create and sustain an agile supply chain.
Prof Clive Badman OBE
Presentation at EIPG - Royal Pharmaceutical Society Scientific Symposium "Advances in Technology Impacting the Pharmaceutical Industry" at the University of Strathclyde, Glasgow 2015.
Ongoing, monthly FSMA webcast series featuring The Acheson Group.
In the April 2018 session, Cameron Prince, Senior Food Safety Director with The Acheson Group, joined us for an update on current FSMA activities and to discuss the Safe Food For Canadians Act. Cameron provided an overview of the key elements of the act and proposed regulations and the impact on current food safety environment.
To learn more about this ongoing series, visit www.FSMAFridays.com.
7th Pharmacovigilance 2014 “Ensuring safer drugs to market by analyzing latest developments in pharmacovigilance, drug safety and risk management" 21st November 2014, Kohinoor Continental Hotel, Mumbai, India Greetings from Virtue Insight, I am happy to invite you and your colleagues to be a sponsor / delegate for our upcoming conference. The “Ensuring safer drugs to market by analyzing latest developments in pharmacovigilance, drug safety and risk management” at 7th Pharmacovigilance 2014 on 21st November 2014, Kohinoor Continental Hotel, Mumbai, India.Contact:-Tel: +91 9677590192 Email: dinesh@virtueinsight.co.in
The biotech industry is characterised by constant change and fast-paced growth. Keeping up with the rapid evolution is close to impossible. Nevertheless, that’s exactly what Niels Guldager, Senior Technology Partner within biopharmaceuticals, does best. In this slide series, he presents the top ten biotech trends as he sees them.
Counterfeit Herbal Medicine adulterated with chemical drugs in Indonesia: NAD...Premier Publishers
Herbal medicine is widely used in Indonesia. Thus, counterfeit herbal medicines are a great concern given the negative impact to individual and population health. This paper used data drawn from the National Agency of Drug and Food Control (NADFC/BPOM)of Indonesia to describe the counterfeit trend against registered herbal drugs from 2011 to 2014, and further analyses were performed to discover the types of the fraud, the impact to the health and conventional drugs that could be used as substitutes for herbal drugs. The research found that the amount of falsified medicines is increasing along with the increasing number of registered herbal drugs. From the data obtained, similar falsified herbal drugs were identified for both life style drugs (51%) and health-related condition drugs (49%). In addition, almost all falsified herbal drugs are adulterations plus tampering (81%). The most significant substitute chemical drug is paracetamol.
Counterfeit Products are epidemic in all product categories, but - unlike luxury goods – fakes and counterfeit pharmaceutical products endanger lives, either through their lack of active ingredients or the inclusion of harmful substances.
(The WHO estimates that over 30% of pharmaceuticals in developing countries are fake).
In this document, we would like to request your support for a field study of our latest mobile visual forensics application that is intended to provide quick, reliable and cost effective identification of counterfeit pharmaceutical goods.
http://www.e-mundo.de
From documents to datasets and back: challenges and solutions Jan Voskuil
The upcoming effectuation of the IDMP directive (EU) forces pharma companies to submit datasets instead of documents. Based on state of the art entity extraction software, a solution is developed that generates those parts of the dataset that can be obtained from the text. The presentation describes some of the major challenges that had to be overcome and details the solutions that were found. It presents some results and describes the major business requirements that need to be met. Recognizing named entities, such as headache and nausea, in the text is not enough. The extraction software needs to be embedded in a layer of software that analyses the text and recognizes which entities are the value of which properties.
The Falsified Medicines Directive - Regulation Driving DigitisationAegate
"The Falsified Medicines Directive - Regulation Driving Digitisation" by Graham Smith of Aegate.
Presented at The European Generic Medicines Association’s Annual Conference, Madrid
June 25-27th 2014
One of the results of the recently approved EU Falsified Medicines Directive imposes the application of a Unique Product Identifier and a Tamper Evidence Feature. This is only the top of the iceberg. It is not just printing a code and adding a label on a box, it means Authentication Data Flow, design the proper IT architecture, learn a new way of handling the products with a precise deadline: February 2019.
From this date all prescription products (with some exceptions)
must be serialized and data must be loaded into the EU hub.
Sharp can support you, thanks to 8 years of experience, 2 billions of sales units serialized to date, 4 plants already serializing for USA (US Drug Quality Security Act enforced from 27th November 2017), China, Brazil, South Corea.
Pharma datamatrix identification and serialisationZetes srl
Learn how our solution offers protection against
1
Counterfeit: unauthorized product introduced into the legitimate distribution network
2
Theft: stolen from the legitimate distribution network
3
Derivations: unauthorized sale of a product based upon contractual restrictions (ex: subcontractor manufacturer)
Best Practices in the Field of Serialization and Safe Supply Chain László Árvai
GS1 – and global standards • ABC – Argentina, Brasil, China and other countries – what is the world doing beyond Europe? • Serialisation – how and when? • Visibility in the supply chain – reality or myth • Patient Safety and the “Level below the Each”
Presented at World Conference Cold chain - Thaifex 2013. Opportunity and Challenges in emerging markets, case study India. Cold chain development, the need and the success in hand. Market prospects for cold chain in emerging markets with focus on India.
Global Biopharmaceutical Contract Manufacturing Market - Qualitative and Quan...Aiswariya Chidambaram
This presentation which highlights the key market and technology trends in the global biopharmaceutical contract manufacturing market was delivered as a lecture at the In-Focus Seminar session at CPhI Worldwide 2013 held at Frankfurt, Germany.
IQPC’s Cold Chain MENA summit will combine Supply Chain, Logistics and Quality leaders from Multi-national biopharma companies from the region and around the world as well as government and regulatory figures to discuss issues and proposed solutions that may occur across the supply chain.
For more information, visit www.coldchainmena.com
Highly Potent Active Pharmaceutical Ingredients 2017Fateja Begum
The Highly Potent Active Pharmaceutical Ingredients conference features key speakers of the industry presenting challenges, issues, innovation and new developments in various areas of HPAPI production, development and manufacturing.
5th Annual Pre-Filled Syringes East CoastTeri Arri
Building on the success of previous sell-out shows, SMi Group is delighted to announce the return of the 5th annual conference and exhibition: Pre-Filled Syringes - East Coast, taking place on April 11th – 12th 2018 in Boston, Massachusetts, USA.
A rise in chronic diseases, improvements in technology and a growing demand for easy to use drug administration products has in recent years, created a booming Pre-Filled Syringes industry.
Some notable areas of increased attention have been the broader trends for combination products and biologics, as well as the move towards digital health and improving patient adherence due to increased self-administration figures. As well as these areas of lucrative opportunity, there are still several ongoing challenges that the key-thought leaders are battling to overcome such as chemical compatibility, user safety, high-volume and highly viscous formulation, and non-compliance.
Pre-Filled Syringes East Coast will once again play host to an international audience of drug delivery, medical device and PFS experts to discuss emerging trends and offer innovative solutions to the challenges facing the prefilled industry, helping attendees to secure global success for their PFS device.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Pharmaceutical logistics 2017
1. www.pharmaceutical-logistics.com
Register online or fax your registration to +44 (0) 870 9090 712 or call +44 (0) 870 9090 711
@SMIPHARM
CHAIRS FOR 2017:
• Tony Wright, CEO, Exelsius
• Bob Hayes, Director, Seer Pharma
EXPERT SPEAKER PANEL INCLUDE:
• Glen Hodgson, Head of Healthcare, GS1
• Jim Shaw, Head of Sourcing & Supply, AstraZeneca
• Rebecca Jackson, VR/IWR Manager,
Randomisation and Trial Supply Services,
Johnson and Johnson
• Jasmin Hellwig, Senior Comparator Specialist,
Merck, Sharp and Dohme
• Mark Champ, Logistics Supervisor, GSK
• Gaetano Carubia, TSMS Control Strategy & Process
Monitoring Consultant, Eli Lilly
• Chris Wallace, Senior Director International Supply
Chain, Sanofi Genzyme
• Jason Breakwell, Vice Chairman, TAPA
KEY BENEFITS FOR 2017:
• Gain key regulatory updates and effects of the
newly-implemented EU GDP Guidelines
• Explore the impact of the Falsified Medicines
Directive to the supply chain
• Find out more about the latest innovations in
technology and their applications in clinical trial
logistics
• Discuss approaches to supply chain visibility and
anti-counterfeiting technology
• Discover time and temperature controlled risk
strategies
• Join insightful discussions on pharmaceutical
logistics in emerging markets
18TH - 19TH
MAY
2017
COPTHORNE TARA HOTEL, KENSINGTON, LONDON, UK
SMi Presents the 11th annual conference and exhibition on…
Pharmaceutical
Logistics
Transforming supply chain visibility and management
BOOK BY 31ST JANUARY TO SAVE £400
BOOK BY 28TH FEBRUARY TO SAVE £200
BOOK BY 31ST MARCH TO SAVE £100
2. Pharmaceutical Logistics
Day One | Monday 18th May 2017 www.pharmaceutical-logistics.com
08.30 Registration & Coffee
09.00 Chairman’s Opening Remarks
Tony Wright, CEO, Exelsius
MEETING THE DEMANDS OF TEMPERATURE REGULATION AND WAREHOUSING
09.10 Update on IATA’s Pharma Handling Certification Program CEIV
• discussion on how to improve the level of competency,
operational and technical preparedness for temperature-
sensitive air freight shipments
• What the IATA CEIV Pharma certification program entails
and how it can revolutionise your distribution strategy
• How to approach the issue of the pharma cargo
community collaboration and its present global status
• What the organisation does, how it does it and why it
does it
Francisco Rizzuto, Cargo Specialist Manager, IATA
(International Air Transport Association)
09.50 Shipping GSK’s Crown Jewels, frozen by sea
• How to ship high value discovery samples from Spain to
the US
• Saving more than £250K- how we accomplished this
• Experience of damping the temperature fluctuation
associated with the defrost cycle for the reefer
Mark Champ, Logistics Supervisor, GSK
10.30 Morning Coffee
11.00 Optimising warehouse management
• Moving from 20th to 21st century in material management
and storage
• Technology enabled solutions to ensure accuracy of
inventory, compliance and control
• Three joint changes – new facility, new skills and new
improved process
Jim Shaw, Head of Sourcing & Supply, AstraZeneca
11.40 Qualification of ocean shipments of temperature sensitive
products
• Case study on the qualification exercise we are currently
working on
• Brief background into containers and affect they have on
shipping
• How to develop a robust qualification strategy - the steps
we took to ensure this
• An example of an ocean shipping route and loading plan
• Examples of shipping studies, Process Flow and good
practices when monitoring, shock/ vibration
Gaetano Carubia, TSMS Control Strategy & Process Monitoring
Consultant, Eli Lilly
12.20 Networking Lunch
CHALLENGES WITHIN CLINICAL TRIAL LOGISTICS
13.30 The Impact of Innovation… on the patient, the clinical trial,
the technology, and you
• The increased use of technology in healthcare and what it
means for the patient
• What exactly is ‘innovation’ when applied to clinical
research, and are we really doing it?
• The technical implications of innovation
• How to embrace change and be an Innovation Leader
Rebecca Jackson, Senior Manager, Solution Architecture,
Johnson and Johnson
14.10 Leveraging demand forecasting to optimise supply flow
• Approaches to effective demand planning strategies
• Methods to facilitate short term supply mitigation
• Offshoring of supply chain processes to Bangalore
Juan Francisco del Castillo Mazzini, Senior Supply Chain
Consultant, Novo Nordisk
14.50 Afternoon Tea
15.20 Sourcing comparators for Chinese clinical supplies
• Scenarios in sourcing comparators clinical supplies
- China as case study
• Approaches to maintaining flexibility while matching supply
and demand
• Challenges involved in outsourcing comparator drug
sourcing - what are the ways around this?
• Ways to increase speed of supply
Jasmin Hellwig, Senior Comparator Specialist, MSD
16.00 GDP – Stop talking, more action
• How to implement GDP and work with key stakeholders to
ensure a compliant and secure supply chain
• Case study (Implementing a global GDP complaint QMS for
a 3PL provider
• Developing good relationships and a collaborative
approach to compliance
Amy Shortman, CEO, ASC Associates
16.40 Chairman’s Closing Remarks and Close of Day One
Register online at www.pharmaceutical-logistics.com
OFFICIAL PUBLICATIONS:OFFICIAL MEDIA PARTNER
SPONSORSHIP AND EXHIBITION OPPORTUNITIES
SMi offer sponsorship, exhibition, advertising and branding packages, uniquely tailored to complement your company’s marketing strategy. Prime
networking opportunities exist to entertain, enhance and expand your client base within the context of an independent discussion specific to your
industry. Should you wish to join the increasing number of companies benefiting from sponsoring our conferences please call:
Alia Malick on +44 (0) 20 7827 6168 or email: amalick@smi-online.co.uk
3. Pharmaceutical Logistics
www.pharmaceutical-logistics.com Day Two | Tuesday 19th May 2017
08.30 Registration & Coffee
09.00 Chairman’s Opening Remarks
Bob Hayes, Director, Seer Pharma
STRATEGIES TO MAINTAIN SUPPLY CHAIN SECURITY, VISIBILITY AND
ANTI-COUNTERFEITING
OPENING ADDRESS
09.10 An approach to global supply chain security in the
pharmaceutical industry
• How a pharmaceutical company with a global supply
chain designs and manages its security system to mitigate
the risk of physical damage, diversion, temperature
excursion, bribery and corruption
• Using internal and external networks as well as technology
the presentation highlights the need for a multi-layered
approach
• Demonstrate case studies where incidents occurred
and what the corrective actions were to mitigate
re-occurrences. This will include looking at investigations
such as paper trails, CCTV footage and forensic analysis to
identify the root cause of the incident
• Supply chain routes by road air and sea
Tom Cochrane, Head of Security Operations, Mundipharma
09.50 GS1 standards – a critical tool in the fight against
counterfeiting
• Standards as a tool to prevent counterfeiting
• Regulatory bodies taking action
• Authentication or traceability – Europe & the world
Glen Hodgson, Head of healthcare, GS1
10.30 Morning Coffee
11.00 The impact of the Falsified Medicines Directive to the supply
chain
• Falsified Medicines Directive & Delegated Regulation
• Development of European Medicines Verification Systems
• The cost implications for the operators
• Status of national implementation and latest developments
Martin FitzGerald, Deputy Director General, European
Healthcare Distribution Association (GIRP)
11.40 How TAPA mitigates supply chain security risks
• Identification & evaluation of supply chain Risks
• Intelligence analysis
• Mitigation measures for facilities and transportation
• Collaborative approaches
Jason Breakwell, Vice Chairman, Transported Asset Protection
Association (TAPA)
12.20 Networking Lunch
REGULATORY CONSIDERATIONS
13.30 Developing Time and temperature controlled supply chain
risk strategies for emerging markets: Dedicated to Eurasia and
Middle East
• What makes emerging markets different?
• What are the specific challenges? By region
• What has been Sanofi Genzyme’s approach?
• How has Sanofi Genzyme mitigated the risk(s)?
• What can you do to mitigate your risks?
Chris Wallace, Senior Director International Supply Chain,
Sanofi Genzyme
14.10 Risk Management – Back to Basics
• The regulatory requirement for risk-based approach to GDP
compliance
• Why managing risk efficiently and effectively is good for
business
• Industry trends – FMEA, the preferred methodology
• An FMEA model that works!
Bob Hayes, Director, Seer Pharma
14.50 Afternoon Tea
15.20 Maintaining control and managing supplies to the patients
• Control of movement of supplies to depots and study sites
• Global Shipment Integration
• Monitoring trends in shipping lanes
• Personal experiences of visiting a study site
Details to be confirmed
16.00 Temperature mapping in the Ambient Environment
• Requirements and guidance.
• Types of ambient areas to be mapped; static and mobile
• Temperature logger placement; rationale and practical
applications
• Real example graph profiles
• The control measures used
Chris Bell, Director, TEDAC
16.40 Chairman’s closing remarks and close of day two
Alternatively fax your registration to +44 (0)870 9090 712 or call +44 (0)870 9090 711
SUPPORTED BY
Want to know how you can get involved? Interested in promoting your services to this market?
Contact Honey De Gracia, SMi Marketing on
+44 (0)20 7827 6102 or email: hdegracia@smi-online.co.uk
4. Please complete fully and clearly in capital letters. Please photocopy for additional delegates.
Title: Forename:
Surname:
Job Title:
Department/Division:
Company/Organisation:
Email:
Company VAT Number:
Address:
Town/City:
Post/Zip Code: Country:
Direct Tel: Direct Fax:
Mobile:
Switchboard:
Signature: Date:
I agree to be bound by SMi’s Terms and Conditions of Booking.
ACCOUNTS DEPT
Title: Forename:
Surname:
Email:
Address (if different from above):
Town/City:
Post/Zip Code: Country:
Direct Tel: Direct Fax:
PHARMACEUTICAL LOGISTICS
Conference: 18th - 19th May 2017, Copthorne Tara Hotel, Kensington, London, UK
4 WAYS TO REGISTER
FAX your booking form to +44 (0) 870 9090 712
PHONE on +44 (0) 870 9090 711
ONLINE at www.pharmaceutical-logistics.com
POST your booking form to: Events Team, SMi Group Ltd, Ground & First Floor,
1 Westminster Bridge Road London, SE1 7XW
If you have any further queries please call the Events Team on tel +44 (0) 870 9090 711 or you can email them at events@smi-online.co.uk
Payment: If payment is not made at the time of booking, then an invoice will be issued and must
be paid immediately and prior to the start of the event. If payment has not been received then
credit card details will be requested and payment taken before entry to the event. Bookings within
7 days of event require payment on booking. Access to the Document Portal will not be given until
payment has been received.
Substitutions/Name Changes: If you are unable to attend you may nominate, in writing, another
delegate to take your place at any time prior to the start of the event. Two or more delegates may
not ‘share’ a place at an event. Please make separate bookings for each delegate.
Cancellation: If you wish to cancel your attendance at an event and you are unable to send
a substitute, then we will refund/credit 50% of the due fee less a £50 administration charge,
providing that cancellation is made in writing and received at least 28 days prior to the start of the
event. Regretfully cancellation after this time cannot be accepted. We will however provide the
conferences documentation via the Document Portal to any delegate who has paid but is unable
to attend for any reason. Due to the interactive nature of the Briefings we are not normally able to
provide documentation in these circumstances. We cannot accept cancellations of orders placed
for Documentation or the Document Portal as these are reproduced specifically to order. If we
have to cancel the event for any reason, then we will make a full refund immediately, but disclaim
any further liability.
Alterations: It may become necessary for us to make alterations to the content, speakers, timing,
venue or date of the event compared to the advertised programme.
Data Protection: The SMi Group gathers personal data in accordance with the UK Data Protection
Act 1998 and we may use this to contact you by telephone, fax, post or email to tell you about
other products and services. Unless you tick here □ we may also share your data with third parties
offering complementary products or services. If you have any queries or want to update any of the
data that we hold then please contact our Database Manager databasemanager@smi-online.
co.uk or visit our website www.smi-online.co.uk/updates quoting the URN as detailed above your
address on the attached letter.
Unique Reference Number
Our Reference P-206
Terms and Conditions of Booking
DELEGATE DETAILS
Payment must be made to SMi Group Ltd, and received before the event,
by one of the following methods quoting reference P-206 and the delegate’s
name. Bookings made within 7 days of the event require payment on booking,
methods of payment are below. Please indicate method of payment:
□ UK BACS Sort Code 300009, Account 00936418
□ Wire Transfer Lloyds TSB Bank plc, 39 Threadneedle Street, London, EC2R
8AU
Swift (BIC): LOYDGB21013, Account 00936418
IBAN GB48 LOYD 3000 0900 9364 18
□ Cheque We can only accept Sterling cheques drawn on a UK bank.
□ Credit Card □ Visa □ MasterCard □ American Express
All credit card payments will be subject to standard credit card charges.
Card No: □□□□ □□□□ □□□□ □□□□
Valid From □□/□□ Expiry Date □□/□□
CVV Number □□□□ 3 digit security on reverse of card, 4 digits for AMEX card
Cardholder’s Name:
Signature: Date:
I agree to be bound by SMi’s Terms and Conditions of Booking.
Card Billing Address (If different from above):
DOCUMENTATION
I cannot attend but would like to Purchase access to the following Document
Portal/Paper Copy documentation. Price Total
□ Access to the conference documentation
on the Document Portal £499.00 + VAT £598.80
□ The Conference Presentations – paper copy £499.00 - £499.00
(or only £300 if ordered with the Document Portal)
PAYMENT
VAT
VAT at 20% is charged on the attendance fees for all delegates. VAT is also charged
on Document portal and literature distribution for all UK customers and for those EU
Customers not supplying a registration number for their own country here
CONFERENCE PRICES GROUP DISCOUNTS AVAILABLE
I would like to attend: (Please tick as appropriate) Fee TOTAL
□ Conference only £1499.00 + VAT £1798.80
PROMOTIONAL LITERATURE DISTRIBUTION
□ Distribution of your company’s promotional
literature to all conference attendees £999.00 + VAT £1198.80
The conference fee includes refreshments, lunch, conference papers, and access to
the Document Portal. Presentations that are available for download will be subject
to distribution rights by speakers. Please note that some presentations may not be
available for download. Access information for the document portal will be sent to
the e-mail address provided during registration. Details are sent within 24 hours post
conference.
VENUE Copthorne Tara Hotel, Kensington, London, UK
□ Please contact me to book my hotel
Alternatively call us on +44 (0) 870 9090 711,
email: events@smi-online.co.uk or fax +44 (0) 870 9090 712
□ Book By 31st January to Save £400 off the conference price
□ Book By 28th February to Save £200 off the conference price
□ Book By 31st March to Save £100 off the conference price
EARLY BIRD
DISCOUNT
Fateja Begum